TMS Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Transimex Corp

Watchlist Manager

Watchlist

Price: 37 450 VND -3.48% Market Closed

Market Cap: ₫6.5T

T	Transimex Corp VN:TMS	VN
	BioRestorative Therapies Inc F:9OF	US
B	Banco de Credito e Inversiones SGO:BCI	CL
	Genuit Group PLC LSE:GEN	UK
	Tosho Co Ltd TSE:8920	JP
U	Unisys Corp F:USY1	US
T	technotrans SE DUS:TTR1	DE

Profitability Summary

Transimex Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

18%

Sustainable 3Y Average Gross Margin

17%

Declining Gross Margin

20% > 18%

Low Operating Margin

10%

Low 3Y Average Operating Margin

Declining Operating Margin

11% > 10%

Healthy Net Margin

10%

Low 3Y Average Net Margin

Declining Net Margin

14% > 10%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-7%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.